Key Takeaways

Test choice depends on age, symptoms, medicines, family history, prior results, and whether a result could change prevention, diagnosis, or treatment. A 100-marker panel is not a guideline standard for every healthy adult.

Routine annual bloodwork without a clinical reason can create incidental abnormalities and follow-up work without proven benefit. Age, symptoms, medicines, family history, and prior results commonly guide test choice. [1]
The familiar 64% and 99% flag calculations assume independent tests and a 5% out-of-range probability for each. Real markers can be correlated, and an out-of-range result is not automatically a false positive. [2]
The USPSTF recommends blood pressure screening for adults without known hypertension. It also recommends confirmation with validated home or ambulatory measurements before treatment starts. [3]
The 2026 ADA standard recommends diabetes screening by age 35 for other adults, with earlier screening for adults with overweight or obesity plus risk factors. A1C, fasting glucose, or an oral glucose tolerance test may be used. [4]
The 2026 ACC/AHA dyslipidemia guideline recommends one Lp(a) measurement in adulthood. ApoB is a selective add-on for residual or discordant risk, including diabetes, high triglycerides, cardiovascular-kidney-metabolic syndrome, or known cardiovascular disease. [5]
KDIGO recommends kidney testing with eGFR and urine albumin for people at risk of chronic kidney disease. Current guidelines do not support routine vitamin D or thyroid screening for every asymptomatic, otherwise healthy adult. [6] [7] [8]

Common questions

Is there one minimal blood panel every healthy adult should get each year?

The useful panel varies by age, risk, symptoms, medicines, and prior results. Each test needs a question it can answer and an action that may follow. Current screening guidelines do not define a routine CBC, kidney panel, liver panel, hormone panel, or micronutrient panel as a universal annual package for healthy adults. [1]

Which preventive checks have the clearest support?

Blood pressure screening has strong support for adults without known hypertension, although it is not a blood test. Diabetes screening generally starts by age 35, or earlier with overweight or obesity plus risk factors. Lipid assessment depends on age and cardiovascular risk. The 2026 dyslipidemia guideline adds one adult Lp(a) measurement. The exact interval and panel still depend on prior results, treatment, and risk. [3] [4] [5]

Should everyone add ApoB to a standard lipid panel?

The 2026 ACC/AHA guideline supports selective ApoB use, especially with diabetes, high triglycerides, cardiovascular-kidney-metabolic syndrome, known cardiovascular disease, or suspected residual risk after LDL-C and non-HDL-C goals are reached. ApoB counts atherogenic particles and can clarify risk when LDL-C and particle burden may diverge. [5]

Who needs kidney blood and urine tests?

KDIGO recommends testing people at risk of chronic kidney disease with both a GFR estimate and urine albumin measurement. Risk may come from diabetes, hypertension, cardiovascular disease, family history, prior kidney injury, or medicines and conditions that affect the kidneys. The recommendation is not routine eGFR monitoring for every healthy adult. [6]

Which popular screening tests need more restraint?

The Endocrine Society suggests against routine vitamin D testing in healthy adults without an established indication. The USPSTF finds insufficient evidence to recommend for or against thyroid screening in nonpregnant, asymptomatic adults. An insufficient-evidence statement is uncertainty, not proof that a test is useless. Symptoms, pregnancy, medication, and specific disease risks change the decision. [7] [8]

Can hard training distort blood results?

Yes. In one small study, 15 healthy men completed an unfamiliar heavy weightlifting session; AST, ALT, CK, LD, and myoglobin rose, and several markers remained elevated for at least 7 days. The result does not establish a universal 48-hour rule for every test. A clinician or laboratory needs to know about recent strenuous exercise when it may affect interpretation, and preparation instructions depend on the specific test. [9]

What should happen after one abnormal result?

The response depends on the marker, how abnormal it is, symptoms, and the risk of delay. Some unexpected mild results are commonly repeated under appropriate conditions. Others can require prompt action. The laboratory flag alone does not determine the diagnosis or the next step; clinical context does. [1] [9]

Bloodwork for Healthy Adults: A Decision-First Screening Guide